Creative Bioarray Provides an Expanding Collection of Tumor Cells for Drug Development and Biological Research

August 17 18:59 2021
Creative Bioarray announced the release of its expanding collection of tumor cell types including leukemia/lymphoma/lyeloma cells which can be applied in drug development and other more biological researches.

New York, USA – August 17, 2021 – Creative Bioarray, one of the innovative biotechnology products and services providers, focused on developing unique technologies with the latest technology or proprietary protocols in order to promote the investigation of pharmaceutical, biotechnology and diagnostics industries. Currently, Creative Bioarray announced the release of its expanding collection of tumor cell types including leukemia/lymphoma/lyeloma cells which can be applied in drug development and other more biological researches.

Tumor cell lines are ideal for studying cellular pathways affected by tumorogenesis, Creative Bioarray offers a collection of human and animal cell lines for experimental needs. In order to create powerful tools for cancer research and drug discovery, Creative Bioarray has launched a variety of tumors by combining validated and well-characterized cell lines with mutation data from the Sanger Institute’s Cancer Somatic Mutation Catalog (COSMIC) Cell panel. Each cell line has been validated by STR and tested for Mycoplasma, and is usually used in various small and large molecule research projects.

Creative Bioarray has launched tumor cell panels based on tissue sources, each panel is accompanied by detailed information about known mutations, making tumor cell lines a more powerful research model and drug discovery tool. Besides, Creative Bioarray has produced a variety of tumor cell lists based on the gene mutation information in the COSMIC database of the Sanger Institute, so as to choose cell-based research models while giving smarter choices.

Creative Bioarray offers a broad product portfolio, covering tissue samples, tissue arrays, cells, microorganisms and probes. Tissue samples include tissue sections, blocks, blood, RNA, DNA, and body fluids from humans and animals. Cells include tumor cells, primary cells, and stem cells; cell-related products include culture media, growth factors, cytokines and reagents.

“Our professional team is capable to work with you to develop and perform flexible custom-designed experiments that meet your unique needs and goals.” said Hannah Cole, the marketing director of Creative Bioarray, she also said, “We are always dedicated to offering cutting-edge products and high quality services to accelerate life sciences research, solve complex analytical challenges and increase laboratory productivity.”

About Creative Bioarray

Founded in 2005, Creative Bioarray is dedicated to offering customers with innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house experts supported, Creative Bioarray has already countenanced research all around the world.

Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-386-8241
Country: United States
Website: https://www.creative-bioarray.com